Admera’s Portfolio employs state-of-the-art genomics
technology, allowing for rapid screening of multiple genes
in parallel. All results are delivered in an actionable report,
allowing physicians to provide personalized healthcare to
their patients, based on their unique and specific needs.
Admera’s Product Portfolio
PGxOne™ Plus is a comprehensive pharmacogenomics (PGx) test that includes over 60 genes and 200 variants
Admera Health’s Oncology Test Portfolio spans the continuum of patient care. Included tests for supportive care, blood based non-invasive cancer testing, and comprehensive tumor profiling
Admera Health’s unique Cardiovascular Test Portfolio includes a suite of tests to aid in risk assessment, diagnosis, and treatment decisions for a wide range of cardiovascular disease conditions